Voxel

Voxel Financial Leverage

The Financial Leverage (Equity Multiplier) of Voxel (VOX.WA) as of Oct 21, 2026 is 1.73. In the previous year, Financial Leverage (Equity Multiplier) was 1.77 — a change of -2.55% (lower).

Financial Leverage

1.73

YoY

-2.55%

Last updated:

Financial Leverage (Equity Multiplier) of Voxel is 2025 1.73 . Financial Leverage (Equity Multiplier) of Voxel was 2024 1.77 . It decreases by -2.55% lower compared to the previous year.

The Voxel Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.97 PLN
Jan 1, 2019
2.17 PLN
Jan 1, 2020
2.44 PLN
Jan 1, 2021
2.16 PLN
Jan 1, 2022
1.93 PLN
Jan 1, 2023
1.80 PLN
Jan 1, 2024
1.77 PLN
Jan 1, 2025
1.73 PLN
The Voxel Financial Leverage history
YEARFinancial LeverageYoY
1.73-2.55%
1.77-1.68%
1.80-6.64%
1.93-10.64%
2.16-11.28%
2.44+12.31%
2.17+10.02%
1.97+7.48%
1.83-4.39%
1.92+0.44%
1.91-8.03%
2.08—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Voxel Stock analysis

What does Voxel do? Voxel SA generates revenue through medical services including diagnostic imaging, teleradiology, and outsourcing, alongside IT systems for hospitals and diagnostic centers. The company serves healthcare institutions with its diagnostic imaging solutions, teleradiology services, and IT infrastructure, targeting hospitals and diagnostic centers as key clients. It operates two subsidiaries, Alteris SA (95.24%-owned) and CDO Sp. z o.o. (wholly owned), which support its service offerings. Voxel SA previously held a stake in Centrum Diagnostyki i Terapii Onkologicznej Sp. z o.o. but sold it on November 7, 2012. The company's primary revenue streams come from providing diagnostic imaging services, teleradiology, and IT systems to healthcare facilities. Its subsidiaries, Alteris SA and CDO Sp. z o.o., contribute to the delivery of these services, enhancing its market presence in medical technology. Voxel SA focuses on institutional clients such as hospitals and diagnostic centers, leveraging its IT systems to improve operational efficiency in healthcare settings. Voxel SA's business model centers on delivering specialized medical services and technology solutions to healthcare providers. It operates through its subsidiaries, Alteris SA and CDO Sp. z o.o., to expand its service capabilities. The company's revenue is derived from contracts with hospitals and diagnostic centers for diagnostic imaging, teleradiology, and IT system implementation, with no mention of additional revenue sources beyond these core services. Voxel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Voxel stock

Financial Leverage (Equity Multiplier) of Voxel is 1.73 in 2025.

Financial Leverage (Equity Multiplier) of Voxel changed from 1.77 to 1.73, representing a -2.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Voxel since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Voxel with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Voxel

All Key Metrics — Voxel